Charter Communications Enhances Offer for Liberty Broadband in Revised Takeover Deal American Consumer Confidence Hits Record Low in May Economists Question Recovery Timeline From Service to Skilled Trades The Untapped Pipeline Reshaping Americas Labor Market MTAR Technologies Shares Retreat 3 After 24 Rally International Orders and Raised Guidance Underpin Outlook Plus500 Reports 11 Revenue Growth in Latest Quarter Reaffirms FullYear Expectations Global Stocks Rise Bond Yields Fall as USIran Talks Show Signs of Progress PVL Q1 2023 Earnings Trust Reports Solid EPS Amid Quiet Quarter Stock Rises GEG Q1 2026 Earnings Substantial EPS Miss Triggers Stock Decline STOK Q1 2026 Earnings EPS Surprises to the Upside as Clinical Pipeline Advances HYPD Q1 2026 Earnings Significant EPS Miss Sends Stock Down Over 7 VPG Q1 2026 Earnings EPS Surprise Beats Zero Estimate Stock Jumps American Healthcare REIT Inc AHR Q1 2026 Earnings Strong EPS Beat Amidst Operational Improvements SIBONE Inc SIBN Edges Lower Amid Consolidation Near Key Support Levels CION Investment Corporation Notes CICC Edge Lower Amid Rate Sensitivity and Yield Comparisons Chewy CHWY Holds Steady at Range Midpoint Amid Low Volatility BioXcel Therapeutics BTAI Falls Further as Biotech Struggles to Hold Support Ascent Solar Technologies ASTI Surges 12 as Momentum Builds Above Key Support Coal India OFS Opens for Retail Investors Government to Sell Up to 2 Stake at 11 Discount SP 500 Edges Higher as Healthcare and Technology Lead BroadBased Gains Nvidia Stock in Focus June 2 Event May Shape AI Chip Market Outlook TakeTwo Reaffirms GTA VI November Launch Despite Weaker Annual Bookings Forecast Oil Prices Plunge Over 5 as Iran Nuclear Deal Hopes Intensify Manufacturing Employment Data Underscore Uneven Impact of TrumpEra Tariffs Cato Institute Analysis Suggests QYLDs High 12 Yield Could Attract Income Seekers but LongTerm Total Return Raises Questions iBio Inc IBIO Q1 2026 Earnings EPS Miss on Higher RD Spend Stock Rises Despite No Revenue Fractyl Health GUTS Dips Near Key Support After 662 Decline Biotech Volatility Continues